Biliary Cystadenoma
Biliary cystadenoma—now more commonly called mucinous cystic neoplasm of the liver or biliary tract—is a rare cystic tumor that arises from cells related to the bile ducts. It is typically benign but is considered to have malignant potential, with rare progression to biliary cystadenocarcinoma. Most are slow-growing and discovered incidentally in middle-aged women. Because of the risk of growth, recurrence after incomplete treatment, and possible malignant transformation, complete surgical removal is generally recommended. Imaging—particularly MRI with MR cholangiopancreatography (MRCP)—is central to diagnosis.
What is it?
A biliary cystadenoma is a rare cystic tumor that arises within the liver or the biliary tree from cells related to the bile duct lining. In modern pathology classifications, these tumors are often described as mucinous cystic neoplasms (MCNs) of the liver or biliary tract. They typically appear as well-defined, complex cysts that contain thick mucinous (mucus-like) or serous fluid and are surrounded by a fibrous capsule. The cysts often have internal walls (septations) and may have small, solid nodular areas along their lining. A distinctive pathological feature in many cases is a specialized “ovarian-type” stroma in the wall of the cyst, particularly in women.
Although biliary cystadenoma is typically a benign tumor, it has well-recognized malignant potential. A small but real proportion of these lesions transform over time into biliary cystadenocarcinoma, a related malignant cystic tumor. This potential—combined with the tendency of biliary cystadenomas to slowly grow, recur if not completely removed, and occasionally cause symptoms—is the reason complete surgical removal is generally recommended.
The cause of biliary cystadenoma is not well understood. Most cases occur in adults, with a strong predominance in middle-aged women, suggesting hormonal influences in many patients. The lesions can occur anywhere in the liver but are most commonly found in the right lobe, and they may also arise in the major bile ducts or, rarely, the gallbladder. They are unrelated to common simple hepatic cysts and to polycystic liver disease.
Many biliary cystadenomas cause no symptoms when small and are discovered incidentally on abdominal imaging done for other reasons. As the lesion grows, symptoms can develop and most often include upper right abdominal pain or fullness, a vague sense of heaviness, early fullness with meals, nausea, or—when the lesion is large—a palpable mass. Cysts that arise near major bile ducts or compress them can cause jaundice, dark urine, pale stools, or itching. Less commonly, complications such as bleeding within the cyst, infection (which may produce fever and worsening pain), or rupture can occur.
Diagnosis combines clinical assessment with imaging and, in selected cases, additional studies. Ultrasound often identifies a multilocular (multi-chambered) cystic liver lesion. CT with contrast provides detailed information about size, location, internal septations, solid nodules, calcifications, and relationship to the bile ducts and surrounding structures. MRI with contrast and MR cholangiopancreatography (MRCP) is particularly valuable because it characterizes the cyst contents, identifies internal architecture, and visualizes the biliary tree. Features such as multiple internal septations, mural nodules, thickened walls, or solid components raise concern for biliary cystadenoma and—particularly when solid components are prominent—biliary cystadenocarcinoma.
Distinguishing a biliary cystadenoma from a simple hepatic cyst, a complicated cyst, a hydatid (echinococcal) cyst, an intraductal papillary neoplasm of the bile duct (IPNB), or another cystic lesion is sometimes challenging on imaging alone. In selected cases, endoscopic ultrasound, image-guided sampling, or evaluation by a multidisciplinary team helps clarify the diagnosis. Cyst fluid analysis can sometimes provide helpful information (such as elevated CA 19-9 and CEA, or specific cytology), although such testing is interpreted carefully because it can also have limitations. When the diagnosis is reasonably suspected based on imaging and clinical features, the standard of care in most experienced centers is to proceed to definitive surgical resection rather than relying on percutaneous biopsy or aspiration alone, both because of the risk of recurrence and the need to evaluate the entire lesion for malignancy.
Important to Know
The mainstay of treatment for a confirmed or strongly suspected biliary cystadenoma is complete surgical removal. Simple drainage or aspiration of the cyst contents is generally not adequate because the lesion almost always recurs and because focal areas of malignancy may be missed without examining the entire cyst wall. Treatment is typically delivered in centers with experience in hepatobiliary surgery and managing complex liver lesions.
Surgical options depend on the size and location of the lesion. Liver resection—removing a segment, multiple segments, or a lobe of the liver containing the cyst—is the most common approach and offers the best chance of cure. In selected, well-encapsulated, easily separable lesions, enucleation (removal of the cyst with its capsule from the surrounding liver tissue) may be considered. Cystadenomas involving the major bile ducts or extending close to important vascular structures may require more complex hepatobiliary surgery. After complete resection, the long-term outlook is generally excellent for benign biliary cystadenomas.
When pathology after resection shows biliary cystadenocarcinoma, additional treatment may be considered based on the depth of invasion, surgical margins, and overall stage. This may include further surgery, chemotherapy, or radiation, with care coordinated by hepatobiliary surgeons, medical oncologists, and radiation oncologists.
Surveillance after successful complete resection is generally favorable, with low recurrence rates. Periodic imaging may be recommended for a period of time after surgery, with frequency individualized based on pathology findings and overall risk.
For patients in whom the diagnosis is uncertain—for example, when imaging features overlap with other cystic conditions—careful evaluation by a multidisciplinary team is important. Patients should generally be cautioned that simple drainage of a lesion thought to be a biliary cystadenoma is rarely a definitive solution and may delay appropriate treatment.
Lifestyle measures—such as healthy diet, regular physical activity, weight management, and limited alcohol—support overall liver and cardiovascular health but do not directly affect the behavior of a biliary cystadenoma.
Care is typically coordinated by primary care clinicians, hepatologists, gastroenterologists, hepatobiliary surgeons, interventional radiologists, and—when relevant—oncologists. Imaging findings are interpreted alongside the patient’s symptoms, examination, and broader clinical context rather than in isolation.
Red flag symptoms include severe upper right abdominal pain, persistent vomiting, jaundice, dark urine, pale stools, high fever with chills (which may suggest infection), signs of gastrointestinal bleeding, rapidly enlarging abdominal mass, or signs of shock. These warrant prompt or urgent medical evaluation.